The CCN family of angiogenic regulators: The integrin connection

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 44-57

  Lau, Lester F ^a   Lam, Stephen C T ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBRONECTIN; INTEGRIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; CARCINOGENESIS; CELL ADHESION; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SHORT SURVEY;

EID: 0033541389     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4456     Document Type: Article

References (101)

1. Almendral J. M., Sommer D., MacDonald Bravo H., Burckhardt J., Perera J., Bravo R. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol. Cell. Biol. 8:1988;2140-2148.
2. Babic A. M., Chen C.-C., Lau L. F. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αVβ3, promotes endothelial cell survival, and induces angiogenesisin vivo. Mol. Cell. Biol. 19:1999;2958-2966.
3. Babic A. M., Kireeva M. L., Kolesnikova T. V., Lau L. F. CYR61, product of a growth factor-inducible immediate-early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA. 95:1998;6355-6360.
4. Ball, D. K. Surveyor, G. A. Diehl, J. R. Steffen, C. L. Uzumcu, M. Mirando, M. A. Brigstock, D. R. 1998, Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings, Biol. Reprod. 59, 1554, 1998, Biol Reprod. 59, 828, 835.
5. Ball, D. K. Surveyor, G. A. Diehl, J. R. Steffen, C. L. Uzumcu, M. Mirando, M. A. Brigstock, D. R. 1998, Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings, Biol. Reprod. 59, 1554, 1998, Biol Reprod. 59, 828, 835.
6. Boehm T., Folkman J., Browder T., O'Reilly M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:1997;404-407.
7. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327:1993;125-130.
8. Bornstein P. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J. Cell Biol. 130:1995;503-506.
9. Bouck N., Stellmach V., Hsu S. C. How tumors become angiogenic. Adv. Cancer Res. 69:1996;135-174.
10. Bradham D. M., Igarashi A., Potter R. L., Grotendorst G. R. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1991;1285-1294.
11. Brigstock D. R., Steffen C. L., Kim G. Y., Vegunta R. K., Diehl J. R., Harding P. A. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J. Biol Chem. 272:1997;20275-20282.
12. Brooks P. C., Clark R. A. F., Cheresh D. A. Requirement of vascular integrin αVβ3 for angiogenesis. Science. 264:1994;569-571.
13. Brooks P. C., Montgomery A. M. P., Rosenfeld M., Reisfel R., Hu T., Klier G., Cheresh D. Integrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79:1994;1157-1164.
14. Brooks P. C., Stromblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αVβ3. Cell. 85:1996;683-693.
15. Brunner A., Chinn J., Neubauer M., Purchio A. F. Identification of a gene family regulated by transforming growth factor-β DNA Cell Biol. 10:1991;293-300.
16. Chevalier G., Yeger H., Martinerie C., Laurent M., Alami J., Schofield P. N., Perbal B. novH: Differential expression in developing kidney and Wilm's tumors. Am. J. Pathol. 152:1998;1563-1575.
17. Chung K. C., Ahn Y. S. Expression of immediate early gene cyr61 during the differentiation of immortalized embryonic hippocampal neuronal cells. Neurosci. Lett. 255:1998;155-158.
18. Clark E. A., Brugge J. S. Integrins and signal transduction pathways: The road taken. Science. 268:1995;233-239.
19. Dammeier J., Brauchle M., Falk W., Grotendorst G. R., Werner S. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int. J. Biochem. Cell Biol. 30:1998;909-922.
20. Folkman J. Blood vessel formation: What is its molecular basis. Cell. 87:1997;1153-1155.
21. Folkman J. Antiangiogenic gene therapy. Proc. Natl. Acad. Sci. USA. 95:1998;9064-9066.
22. Fox J. E. Platelet activation: New aspects. Haemostasis. 26:1996;102-31-102-131.
23. Francois V., Solloway M., O'Neill J. W., Emery J., Bier E. Dorsal-ventral patterning of theDrosophilashort gastrulation. Genes Dev. 8:1994;2602-2616.
24. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G. R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107:1996;404-411.
25. Frazier K. S., Grotendorst G. R. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int. J. Biochem. Cell Biol. 29:1997;153-161.
26. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Varner J. A., Cheresh D. A. Definition of two angiogenic pathways by distinct αV integrins. Science. 270:1995;1500-1502.
27. Grotendorst G. R. Connective tissue growth factor: A mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev. 8:1997;171-179.
28. Grotendorst G. R., Okochi H., Hayashi N. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 7:1996;469-480.
29. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
30. Hashimoto Y., Shindo-Okada N., Tani M., Nagamachi Y., Takeuchi K., Shiroishi T., Toma H., Yokota J. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppressesin vivo. J. Exp. Med. 187:1998;289-296.
31. Herschman H. R. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60:1991;281-319.
32. Holt G. D., Pangburn M. K., Ginsburg V. Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. J. Biol Chem. 265:1990;2852-2855.
33. Hynes R. O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
34. Hynes R. O. Targeted mutations in cell adhesion genes: What have we learned from them? Dev. Biol. 180:1996;402-412.
35. Igarashi A., Bradham D. M., Okochi H., Grotendorst G. R. Connective tissue growth factor. J. Dermatol. 19:1992;642-643.
36. Igarashi A., Hayashi N., Nashiro K., Takehara K. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J. Cutan. Pathol. 25:1998;143-148.
37. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Fujimoto M., Grotendorst G. R., Takehara K. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 106:1996;729-733.
38. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Grotendorst G. R., Takehara K. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105:1995;280-284.
39. Igarashi A., Okochi H., Bradham D. M., Grotendorst G. R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell. 4:1993;637-645.
40. Ito Y., Aten J., Bende R. J., Oemar B. S., Rabelink T. J., Weening J. J., Goldschmeding R. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int. 53:1998;853-861.
41. Jackson D., Volpert O., Bouck N., Linzer D. I. H. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science. 266:1994;1581-1584.
42. Jay P., Berge-Lefranc J. L., Marsollier C., Mejean C., Taviaux S., Berta P. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene. 14:1997;1753-1757.
43. Jedsadayanmata, A. Chen, C.-C. Kireeva, M. L. Lau, L. F. Lam, S. C. T. 1999, Activation-dependent adhesion of human platelets to connective tissue growth factor (CTGF) and CYR61 is mediated through integrin αIIbβ3.
44. Joliot V., Martinerie C., Dambrine G., Plassiart G., Brisac M., Crochet J., Perbal B. Proviral rearrangements and overexpression of a new cellular gene (nov. Mol. Cell. Biol. 12:1992;10-21.
45. Kim H. S., Nagalla S. R., Oh Y., Wilson E., Roberts C. T. J., Rosenfeld R. G. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA. 94:1997;12981-12986.
46. Kireeva M. L., Lam S. C. T., Lau L. F. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αVβ3. J. Biol. Chem. 273:1998;3090-3096.
47. Kireeva M. L., Latinkic B. V., Kolesnikova T. V., Chen C.-C., Yang G. P., Abler A. S., Lau L. F. Cyr61and Fisp12 are both signaling cell adhesion molecules: Comparison of activities, metabolism, and localization during development. Exp. Cell Res. 233:1997;63-77.
48. Kireeva M. L., Mo F.-E., Yang G. P., Lau L. F. Cyr61, product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol. Cell. Biol. 16:1996;1326-1334.
49. Kolesnikova T. V., Lau L. F. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene. 1998.
50. Kothapalli D., Frazier K. S., Welply A., Segarini P. R., Grotendorst G. R. Transforming growth factor β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 8:1997;61-68.
51. Lam S. C. T., Plow E. F., Smith M. A., Andrieux A., Ryckwaert J. J., Marguerie G., Ginsberg M. H. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. J. Biol Chem. 262:1987;947-950.
52. Lasky J. A., Ortiz L. A., Tonthat B., Hoyle G. W., Corti M., Athas G., Lungarella G., Brody A., Friedman M. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am. J. Physiol. 275:1998.
53. Latinkic, B. V. 1994.
54. Latinkic B. V., O'Brien T. P., Lau L. F. Promoter function and structure of the growth factor-inducible immediate early genecyr61. Nucleic Acids. Res. 19:1991;3261-3267.
55. Lau L. F., Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J. 4:1985;3145-3151.
56. Lau L. F., Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fosmyc. Proc. Natl. Acad. Sci. USA. 84:1987;1182-1186.
57. Lau L. F., Nathans D. Genes induced by serum growth factors. Molecular Aspects of Cellular Regulation, Vol. 6. Hormonal Regulation of Transcription. 1991;Elsevier, Amsterdam. p. 257-293.
58. Maisonpierre P. C., Suri C., Jones P. F., Bartunkova S., Wiegand S. J., Radziejewski C., Comption D., McClain J., Aldrich T. H., Papadopoulos N., Daly T. J., Davis S., Sato T. N., Yancopoulos G. D. Aniopoietin-2, a natural antagonist for Tis2 that disruptsin vivo. Science. 277:1997;55-60.
59. Martinerie C., Chevalier G., Rauscher F. J., Perbal B. Regulation of nov by WT1: A potential role for nov in nephrogenesis. Oncogene. 12:1996;1479-1492.
60. Martinerie C., Huff V., Joubert I., Badzioch M., Saunders G., Strong L., Perbal B. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene. 9:1994;2729-2732.
61. Mason E. D., Konard K. D., Webb C. D., Marsh J. L. Dorsal midline fate inDrosophilatwisted gastrulation, Genes Dev. 8:1994;1489-1501.
62. Murphy M., Godson C., Cannon S., Kato S., Mackenzie H. S., Martin F., Brady H. R. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J. Biol Chem. 274:1999;5830-5834.
63. Nakanishi T., Kimura Y., Tamura T., Ichikawa H., Yamaai Y., Sugimoto T., Takigawa M. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem. Biophys. Res. Commun. 234:1997;206-210.
64. Nathans D., Lau L. F., Christy B., Hartzell S., Nakabeppu Y., Ryder K. Genomic response to growth factors. Cold Spring Harb. Symp. Quant. Biol. 53:1988;893-900.
65. Nishida T., Nakanishi T., Shimo T., Asano M., Hattori T., Tamatani T., Tezuka K., Takigawa M. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem. Biophys. Res. Commun. 247:1998;905-909.
66. O'Brien T. P., Lau L. F. Expression of the growth factor-inducible immediate early genecyr61. Cell Growth Differ. 3:1992;645-654.
67. O'Brien T. P., Yang G. P., Sanders L., Lau L. F. Expression ofcyr61, Mol. Cell. Biol. 10:1990;3569-3577.
68. Oemar B. S., Luscher T. F. Connective tissue growth factor: Friend or foe? Arterioscler. Thromb. Vasc. Biol. 17:1997;1483-1489.
69. Oemar B. S., Werner A., Garnier J. M., Do D. D., Godoy N., Nauck M., Marz W., Rupp J., Pech M., Luscher T. F. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 95:1997;831-839.
70. Pennica D., Swanson T. A., Welsh J. W., Roy M. A., Lawrence D. A., Lee J., Brush J., Taneyhill L. A., Deuel B., Lew M., Watanabe C., Cohen R. L., Melhem M. F., Finley G. G., Quirke P., Goddard A. D., Hillan K. J., Gurney A. L., Botstein D., Levine A. J. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA. 95:1998;14717-14722.
71. Perbal B., Martinerie C., Sainson R., Werner M., He B., Roizman B. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: A clue for a role of NOVH in cell-adhesion signaling. Proc. Natl. Acad. Sci. USA. 96:1999;869-874.
72. Piali L., Hammel P., Uherek C., Bachmann F., Gisler R. H., Dunon D., Imhof B. A. CD31/PECAM-1 is a ligand for αVβ3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130:1995;451-460.
73. Pilarsky C. P., Schmidt U., Eissrich C., Stade J., Froschermaier S. E., Haase M., Faller G., Kirchner T. W., Wirth M. P. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer. Prostate. 36:1998;85-91.
74. Rivera-Gonzalez R., Petersen D. N., Tkalcevic G., Thompson D. D., Brown T. A. Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen. J. Steroid Biochem. Mol. Biol. 64:1998;13-24.
75. Roberts A. B., McCune B. K., Sporn M. B. TGF-β: Regulation of extracellular matrix. Kidney Int. 41:1992;557-559.
76. Roberts A. B., Sporn M. B. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-β Am. Rev. Respir. Dis. 140:1989;1126-1128.
77. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:1996;697-715.
78. Rusnati M., Tanghetti E., Dell'Era P., Gualandris A., Presta M. αvβ 3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol. Biol. Cell. 8:1997;2449-2461.
79. Ryseck R.-P., Macdonald-Bravo H., Mattei M.-G., Bravo R. Structure, mapping, and expression offisp-12, Cell Growth Differ. 2:1991;225-233.
80. Schlunegger M. P., Grutter M. G. Refined crystal structure of human transforming growth factor β 2 at 1.95 A resolution. J. Mol. Biol. 231:1993;445-458.
81. v-src. Mol. Cell. Biol. 16:1996;481-486.
82. Schutze N., Lechner A., Groll C., Siggelkow H., Hufner M., Kohrle J., Jakob F. The human analog of murine cysteine-rich protein 61 is a 1α,25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: Regulation by cytokines, growth factors, and serum. Endocrinology. 139:1998;1761-1770.
83. Schwartz M. A., Schaller M. D., Ginsburg M. H. Integrins: Emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11:1995;549-599.
84. Shattil S. J., Kashiwagi H., Pampori N. Integrin signaling: The platelet paradigm. Blood. 91:1998;2645-2657.
85. Simmons D. L., Levy D. B., Yannoni Y., Erikson R. L. Identification of a phorbol ester-repressible v-src. Proc. Natl. Acad. Sci. USA. 86:1989;1178-1182.
86. Solursh M. Cell and matrix interactions during limb chondrogenesisin vitro. Trelstad R. The Role of Extracellular Matrix in Development. 1984;277-303 A. R. Liss, New York.
87. Steffen C. L., Ball-Mirth D. K., Harding P. A., Bhattacharyya N., Pillai S., Brigstock D. R. Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cellsin vitro. Growth Factors. 15:1998;199-213.
88. Strieter R. M., Polverini P. J., Kunkel S. L., Arenber D. A., Burdick M. D., Kasper J., Dzuiba J., Van Dammes J., Walz A., Marriott D., Chan S.-Y., Roczniak S., Shanafelt A. B. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:1995;27348-27357.
89. Suri C., Jones P. F., Patan S., Bartunkova S., Maisonpierre P. C., Davis S., Sato T. N., Yancopoulos G. D. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
90. Surveyor G. A., Wilson A. K., Brigstock D. R. Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol. Reprod. 59:1998;1207-1213.
91. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:1995;4905-4913.
92. Varner J. A. The role of vascular cell integrins αVβ3 and αVβ5 in angiogenesis. Goldberg I. D., Rosen E. M. Regulation of Angiogenesis. 1997;361-390 Birkhauser Verlag, Basel.
93. Wary K. K., Mainiero F., Isakoff S. J., Marcantonio E. E., Giancotti F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733-743.
94. Wenger C., Ellenrieder V., Alber B., Lacher U., Menke A., Hameister H., Wilda M., Iwamura T., Beger H. G., Adler G., Gress T. M. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene. 18:1999;1073-1080.
95. Williams G. T., Abler A. S., Lau L. F. Regulation of gene expression by serum growth factors. Stein G. S., Lian J. B. Molecular and Cellular Approaches to the Control of Proliferation and Differentiation. 1992;115-162 Academic Press, Orlando.
96. Wong M., Kireeva M. L., Kolesnikova T. V., Lau L. F. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev. Biol. 192:1997;492-508.
97. Woods A., Couchman J. R. Syndecans: Synergistic activators of cell adhesion. Trends Cell Biol. 8:1998;189-192.
98. Yang D. H., Kim H. S., Wilson E. M., Rosenfeld R. G., Oh Y. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J. Clin. Endocrinol. Metab. 83:1998;2593-2596.
99. Yang G. P., Lau L. F. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth & Differ. 2:1991;351-357.
100. Ying Z., King M. L. Isolation and characterization of xnov, aXenopus laevis. Gene. 171:1996;243-248.
101. Zhang R., Averboukh L., Zhu W., Zhang H., Jo H., Dempsey P. J., Coffey R. J., Pardee A. B., Liang P. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol. Cell Biol. 18:1998;6131-6141.